| abstract |
The use of a compound comprising the ** formula ** or a pharmaceutically acceptable salt, ester or amide thereof; in the manufacture of a medicament for the treatment of conditions that require the inhibition of an enzyme whose preferred mode of action is to catalyze the hydrolysis of an ester functionality, said condition being obesity or a disorder related to obesity. |